Paul Spanel, DO
Neurology · la Crosse, WINPI 1134387798
Payments from drug & device makers
What this record shows
This record is dominated by grants: $22,500 of the $23,241 with a category attached, or 96.8%. Boston Scientific accounts for 64.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $15,000 and has fallen 99.4% since, to $83 in 2024. Among neurology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $1660.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$15K
- Medtronic$8K
- MDD US Operations, LLC$120
- Bristol Myers Squibb$120
- Acorda Therapeutics, Inc$108
- Acadia Pharmaceuticals Inc$89
- plus $130 from 3 others
What the payments were for
- Grants$22,50097%
- Food & beverage$7413%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $15,013 |
| Medtronic | 4 | $7,662 |
| MDD US Operations, LLC | 2 | $120 |
| Bristol Myers Squibb | 1 | $120 |
| Acorda Therapeutics, Inc | 1 | $108 |
| Acadia Pharmaceuticals Inc | 1 | $89 |
| Lundbeck LLC | 1 | $83 |
| SK Life Science, Inc. | 1 | $30 |
| Abbott | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,241 in reported general payments places this provider in the 95th percentile of 308 neurology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 25 | $193,163 |
| RytaryCarbidopa/Levodopa | 33 | $49,064 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 901 | $39,059 |
| EmsamSelegiline | 11 | $24,764 |
| Primidone | 130 | $5,448 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 127 | $5,149 |
| Propranolol Hcl ErPropranolol Hcl | 62 | $2,705 |
| AmantadineAmantadine Hcl | 75 | $2,528 |
| Entacapone | 12 | $1,529 |
| Carbamazepine ErCarbamazepine | 29 | $1,353 |
| Gabapentin | 108 | $1,156 |
| Memantine Hcl | 63 | $1,110 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 28 | $951 |
| Donepezil Hcl | 87 | $867 |
| Propranolol Hcl | 26 | $772 |
Paid to pharmacies, not to this prescriber.
Other neurology in la Crosse
- Michael Yangla Crosse$153K
- Michael Doerrlerla Crosse$9K
- Smathorn Thakolwiboonla Crosse$4K
- Bhupendra KhatriMilwaukee$2.5M
- Ahmed ObeidatMilwaukee$1.9M
- Staley BrodMilwaukee$1M
- Daniel LongNeenah$899K
- Traci PurathBurlington$524K
- Ashley HoldridgeWhitefish Bay$368K
- Michael SnyderMadison$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.